2013
Press Releases
-
Genome Sequencing of the Living Coelacanth Sheds Light on the Evolution of Land Vertebrates
-
Benaroya Research Institute Announces $4.4 Million Grant for Type 1 Diabetes
-
Benaroya Research Institute Welcomes New Board Members
-
BRI Researchers Identify Biomarker and Potential Therapy Target in Multiple Sclerosis
2012
Press Releases
-
New Studies Test Artificial Pancreas for Type 1 Diabetes
-
Twelve Puget Sound Buildings to Turn Blue for World Diabetes Day
-
BRI Receives Grand Challenges Explorations Grant for Groundbreaking Research in Global Health and Development
-
Collaborative Grant Looks for Genetic Roots of Type 1 Diabetes
-
New Grant Awards Aim to Prevent Autoimmune Diseases
-
Pioneering Clinical Trial Studies Efforts to Boost Healthy Immune System
-
Research Reveals Unique Solution to Gene Regulation
-
Benaroya Research Institute Promotes Homer W. Lane Jr. to Executive Director
-
Benaroya Research Institute and Novo Nordisk Collaborate on Autoimmune Disease Research
-
Lynn M. Rose, PhD, Joins BRI as First Director of Scientific Administration
-
Jack Nagan, Executive Director, Announces Retirement
Genome Sequencing of the Living Coelacanth Sheds Light on the Evolution of Land Vertebrates
Benaroya Research Institute Announces $4.4 Million Grant for Type 1 Diabetes
Benaroya Research Institute Welcomes New Board Members
BRI Researchers Identify Biomarker and Potential Therapy Target in Multiple Sclerosis
-
New Studies Test Artificial Pancreas for Type 1 Diabetes
-
Twelve Puget Sound Buildings to Turn Blue for World Diabetes Day
-
BRI Receives Grand Challenges Explorations Grant for Groundbreaking Research in Global Health and Development
-
Collaborative Grant Looks for Genetic Roots of Type 1 Diabetes
-
New Grant Awards Aim to Prevent Autoimmune Diseases
-
Pioneering Clinical Trial Studies Efforts to Boost Healthy Immune System
-
Research Reveals Unique Solution to Gene Regulation
-
Benaroya Research Institute Promotes Homer W. Lane Jr. to Executive Director
-
Benaroya Research Institute and Novo Nordisk Collaborate on Autoimmune Disease Research
-
Lynn M. Rose, PhD, Joins BRI as First Director of Scientific Administration
-
Jack Nagan, Executive Director, Announces Retirement
